Sign in
Taking people in United StatesNo phase

Tracking Pain and Opioid Use in Young Sarcoma Survivors

Studies how easy it is to track pain and opioid use in sarcoma survivors.

Key facts

Who runs it
Roswell Park Cancer Institute
Where
Buffalo, United StatesSee the site
Trial code
Registry title
Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
Status
Recruiting
People taking part
40 people, planned
Started
30 Mar 2026
Expected to end
1 Feb 2028
Type of study
Observational
Treatments tested
  • Non Intervention Study
Record updated
15 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young sarcoma survivors who still have meaningful pain from the disease or its treatment. They will answer phone surveys about pain and opioid use for 3 months.

Age
Aged 12-24 at sarcoma diagnosis, and under 70 when joining the study.
Sex
All genders can join.
Disease stage
No sign of disease and/or in survivorship care after sarcoma.
Earlier treatment
Cannot be getting active cancer treatment now.

Main reasons for not taking part

  • Currently getting active cancer treatment
  • Cannot read or speak English fluently
  • Memory or thinking problems that could get in the way of the study
  • Acutely suicidal, or an unstable medical or mental health condition
  • Cannot complete the study tasks

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • All genders between the ages of 12-24 (inclusive) at sarcoma diagnosis
  • Any age < 70 at the time of study enrollment
  • No evidence of disease and/or enrolled in survivorship care
  • Clinically meaningful pain related to disease or its treatments at baseline (defined as 3 or greater on a 0-10 Numerical Rating Scale)
  • Willing to attend the baseline appointment in person
  • Access to internet-capable smartphone
  • Access to internet on an occasional basis
  • Willing and able to complete Ecological Momentary Assessments (EMAs) on internet-capable smartphone for a 3-month period after enrollment
  • Ability to understand and provide informed consent/assent

Who cannot take part

  • * Currently receiving active cancer-directed therapy; Unable to read or fluently speak English; Determined by clinical staff to have preexisting or cancer-associated cognitive impairment that could interfere with study participation; Acutely suicidal (e.g. intent or plan) or, with unstable medical or psychiatric condition verified by licensed study staff; Characteristics related to inability to complete the study protocol

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 70 years old?

Where in United States

  • Roswell Park Comprehensive Cancer CenterBuffalo, United StatesContact: Andrew RogersTaking people

About the trial

What the trial wants to find out

This study generates information on the feasibility and acceptability of a 3-month ecological momentary assessment (EMA) protocol to assess chronic pain and opioid use in adolescent and young adult (AYA) sarcoma survivors.

Treatments tested

  • Non Intervention Study

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
Plain-language title
Tracking Pain and Opioid Use in Young Sarcoma SurvivorsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Fit questions
Built from NCT07402577, who can take part
Record updated
15 April 2026